Opioid use disorder (OUD) in women of child-bearing potential is problematic in the United States. This has resulted in increasing risk for adverse maternal outcomes, neonatal abstinence syndrome, fetal and neonatal harm, prolonged hospitalizations, and increased health care costs. Pharmacists in all practice settings have opportunities to provide preconception and pregnancy care to prevent and manage OUD. Given pharmacists’ scope of practice and expertise, key roles include assessing patients for OUD; mitigating exposure; educating patients regarding potential infant effects; recommending contraceptive methods and counseling on proper use; ensuring safe breastfeeding with concurrent medications; and linking patients to needed services. Through patient counseling, medication management, and harm reduction interventions, pharmacists can work to combat this public health crisis. To encourage increased uptake of pharmacists into these roles, more needs to be done to reimburse pharmacists for these important services and quantify their impact on patient and population health outcomes.

在美国，育龄妇女的阿片类药物使用障碍 (OUD) 存在问题。这导致不良母体结局、新生儿戒断综合征、胎儿和新生儿伤害、住院时间延长和医疗保健成本增加的风险增加。所有实践环境中的药剂师都有机会提供孕前和妊娠护理以预防和管理 OUD。鉴于药剂师的执业范围和专业知识，关键角色包括评估患者的 OUD；减轻暴露；就潜在的婴儿影响对患者进行教育；推荐避孕方法和正确使用的咨询；确保安全母乳喂养同时使用药物；并将患者与所需的服务联系起来。通过患者咨询、药物管理和减少危害干预，药剂师可以努力应对这场公共卫生危机。为了鼓励更多地吸收药剂师担任这些角色，需要做更多的工作来补偿药剂师的这些重要服务，并量化它们对患者和人群健康结果的影响。